阻塞性睡眠呼吸暂停与糖尿病代谢控制及慢性并发症的关联性  

Relationship between obstructive sleep apnea and metabolic control and chronic complications in patients with type 2 diabetes mellitus

作　　者：杜荣慧[1] 肖秘苏 李春燕[3] 关建[3] DU Ronghui;XIAO Misu;LI Chunyan

机构地区：[1]上海交通大学附属第六人民医院内分泌代谢科,上海200233 [2]上海交通大学附属第六人民医院药剂科,上海200233 [3]上海交通大学附属第六人民医院耳鼻咽喉头颈外科,上海市睡眠呼吸障碍疾病重点实验室,上海200233

出　　处：《临床耳鼻咽喉头颈外科杂志》2021年第7期662-666,共5页Journal of Clinical Otorhinolaryngology Head And Neck Surgery

摘　　要：阻塞性睡眠呼吸暂停(obstructive sleep apnea,OSA)是指睡眠时上气道塌陷,导致反复出现完全性或部分性的上气道气流阻塞,引起呼吸暂停和通气不足。有研究报道2型糖尿病(T2DM)患者中OSA的患病率高达8.5%~86.0%,其中中、重度OSA患病率为23.8%~70.0%[1-3]。Obstructive sleep apnea(OSA)is a common sleep apnea disorder.Studies have shown that patients with T2 DM have a higher incidence of OSA,and the latter further increases the difficulty of treating diabetes.This paper describes the adverse effects of OSA on type 2 diabetes patients from the perspective of blood sugar,blood lipids,blood pressure and chronic complications of diabetes,to provide recommendations for clinical treatment of OSA.

关 键 词：睡眠呼吸暂停 阻塞性 2型糖尿病 并发症 

分 类 号：R766.5[医药卫生—耳鼻咽喉科]